Dr. Kate Kass Precision Medicine

Dr. Kate Kass Precision Medicine operates in Bellevue, Washington, providing hormone replacement therapy, medical weight loss, and sexual health treatments through both in-person and telehealth consultations. Dr. Kate Kass, a board-certified physician, leads the practice with a focus on individualized treatment protocols that address hormonal imbalances, metabolic dysfunction, and age-related decline in both men and women. The clinic serves patients throughout Washington state who seek evidence-based interventions for conditions including erectile dysfunction, menopause symptoms, andropause, and obesity-related metabolic disorders.

The medical weight loss program at Dr. Kate Kass Precision Medicine incorporates GLP-1 receptor agonists semaglutide and tirzepatide as pharmaceutical interventions for patients with elevated BMI or metabolic syndrome. These peptide medications work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. Treatment protocols include baseline metabolic panels, body composition analysis, and ongoing monitoring of A1C, lipid profiles, and thyroid function. Dr. Kass adjusts dosing based on individual response patterns and side effect profiles, with most patients following a graduated titration schedule over 16-20 weeks. The program combines medication management with nutritional counseling and metabolic optimization strategies tailored to each patient's hormonal status and health history.

Hormone replacement therapy at the Bellevue clinic addresses testosterone deficiency in men and estrogen/progesterone imbalances in women using bioidentical hormones, pellet therapy, and injectable protocols. For male patients presenting with low testosterone, Dr. Kass evaluates total and free testosterone levels, SHBG, estradiol, and DHT before initiating treatment with testosterone cypionate or enanthate injections, or subcutaneous pellet implants. Female hormone optimization includes estradiol and progesterone replacement for perimenopausal and postmenopausal patients, with delivery methods ranging from transdermal creams to pellet implants based on patient preference and absorption characteristics. Erectile dysfunction treatment combines phosphodiesterase-5 inhibitors with hormonal optimization and, when indicated, peptide therapies that support vascular health and nitric oxide production.

Patients at Dr. Kate Kass Precision Medicine begin with comprehensive intake appointments that include detailed health histories, symptom assessments, and laboratory testing panels specific to their chief complaints. Initial consultations last 45-60 minutes and cover current medications, previous treatment attempts, family history, and lifestyle factors affecting hormonal health. Follow-up visits occur at 6-week intervals during the first three months of treatment, then quarterly once therapeutic targets are achieved. The clinic provides patient education materials explaining the mechanisms of prescribed therapies, expected timelines for symptom improvement, and potential side effects requiring medical attention. Lab work is coordinated through regional Quest Diagnostics and LabCorp facilities, with results reviewed during telehealth follow-ups for patients who prefer remote monitoring.

The hybrid care model allows Washington residents outside the Bellevue area to access Dr. Kass's services through HIPAA-compliant video consultations, with initial visits available via telehealth for established patients of other providers seeking second opinions or treatment optimization. Prescription fulfillment occurs through partnered compounding pharmacies that ship directly to patients, and the clinic coordinates with local phlebotomy services for required lab draws. Dr. Kass maintains hospital privileges at Overlake Medical Center and collaborates with endocrinologists, urologists, and gynecologists when patients require subspecialty evaluation or procedural interventions beyond the scope of precision medicine practice. The clinic accepts select insurance plans for office visits and lab work, though many hormone and peptide therapies require out-of-pocket payment due to coverage limitations for optimization protocols versus disease treatment.